NewsBenzinga60 Degrees Pharmaceuticals To Present Data On Interim Analysis From Its Clinical Trial Of Tafenoquine On Oct. 6 60 Degrees Pharmaceuticals To Present Data On Interim Analysis From Its Clinical Trial Of Tafenoquine On Oct. 6 Benzinga 2026.10.01 12:12 (GMT+0) Open on Benzinga Other news Stock Market Today: Dow, S&P 500 Futures Rise as Bessent Intensifies Economic Pressure on Iran, Treasury Yields Cool Off — TSLA, AA, IBKR in Focus CMA Proposes Designating Microsoft With Strategic Market Status In Business Software, Publishes Intervention Roadmap; Microsoft, Amazon Taking Material Steps To Promote Cloud Choice Piper Sandler Initiates Coverage On iRhythm Holdings with Overweight Rating, Announces Price Target of $160 Goldman Sachs Initiates Coverage On Elanco Animal Health with Buy Rating, Announces Price Target of $32 Elon Musk Floats Amazon Rival After Grok AI Bots Hit Shopping Roadblocks: ‘X Shop’ or ‘Grokazon’? OpenAI launches GPT-Live-1.1, adding voice support for six new languages and improving accent performance
Stock Market Today: Dow, S&P 500 Futures Rise as Bessent Intensifies Economic Pressure on Iran, Treasury Yields Cool Off — TSLA, AA, IBKR in Focus
CMA Proposes Designating Microsoft With Strategic Market Status In Business Software, Publishes Intervention Roadmap; Microsoft, Amazon Taking Material Steps To Promote Cloud Choice
Piper Sandler Initiates Coverage On iRhythm Holdings with Overweight Rating, Announces Price Target of $160
Goldman Sachs Initiates Coverage On Elanco Animal Health with Buy Rating, Announces Price Target of $32
OpenAI launches GPT-Live-1.1, adding voice support for six new languages and improving accent performance
